HomeHealthcare & Life Sciences Schistosomiasis Treatment Market

Schistosomiasis Treatment Market Size, Share, Demand Report By Drug Type (Praziquantel, Combination Therapies, Emerging Antiparasitic Drugs), By Treatment Type (Mass Drug Administration, Targeted Treatment Programs), By End-Use (Government & Public Health Organizations, Private Healthcare Providers, Research & Academic Institutions), By Region & Segment Forecasts, 2025–2034

Starting From
USD 3950

Buy Now

Report Benefits

Develop business strategies by understanding the trends shaping and driving the Market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track sales in the global and country-specific Market.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Executive Summary
1. Introduction
Market Introduction
1. Market Definition
2. Scope of the Study
3. Market Structure
Research Methodology
1. Primary Research
2. Research Methodology
3. Assumptions & Exclusions
4. Secondary Data Sources
Market Factor Analysis
1. Value Chain Analysis: Schistosomiasis Treatment Market
2. Porters Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of Substitution
  4. Threat of New Entrants
  5. Competitive Rivalry
Market Dynamics
1. Drivers
2. Restraints
3. Opportunities
Recent Trends Analysis
Impact of COVID-19 on Schistosomiasis Treatment Market
1. Pre and Post Covid -19 Market Scenario Analysis
2. Market Recovery Timeline and Challenge
3. Measures Taken by Top Players
Regulatory Landscape
Schistosomiasis Treatment Market, Drug Type
1. Introduction
  1. Market Size and Forecast, Drug Type
2. Praziquantel
  1. Market Size and Forecast, By Region
3. Combination Therapies
  1. Market Size and Forecast, By Region
4. Emerging Antiparasitic Drugs
  1. Market Size and Forecast, By Region
Schistosomiasis Treatment Market, Treatment Type
1. Introduction
  1. Market Size and Forecast, Treatment Type
2. Mass Drug Administration
  1. Market Size and Forecast, By Region
3. Targeted Treatment Programs
  1. Market Size and Forecast, By Region
Schistosomiasis Treatment Market, End-Use
1. Introduction
  1. Market Size and Forecast, End-Use
2. Government & Public Health Organizations
  1. Market Size and Forecast, By Region
3. Private Healthcare Providers
  1. Market Size and Forecast, By Region
4. Research & Academic Institutions
  1. Market Size and Forecast, By Region
Regional Overview
1. Introduction
  1. Market Size and Forecast
2. North America
  1. Market Size and Forecast
    1. Drug Type
      1. Praziquantel
      2. Combination Therapies
      3. Emerging Antiparasitic Drugs
    2. Treatment Type
      1. Mass Drug Administration
      2. Targeted Treatment Programs
    3. End-Use
      1. Government & Public Health Organizations
      2. Private Healthcare Providers
      3. Research & Academic Institutions
  2. U.S.
    1. Drug Type
      1. Praziquantel
      2. Combination Therapies
      3. Emerging Antiparasitic Drugs
    2. Treatment Type
      1. Mass Drug Administration
      2. Targeted Treatment Programs
    3. End-Use
      1. Government & Public Health Organizations
      2. Private Healthcare Providers
      3. Research & Academic Institutions
  3. Canada
3. Europe
  1. Market Size and Forecast
    1. Drug Type
      1. Praziquantel
      2. Combination Therapies
      3. Emerging Antiparasitic Drugs
    2. Treatment Type
      1. Mass Drug Administration
      2. Targeted Treatment Programs
    3. End-Use
      1. Government & Public Health Organizations
      2. Private Healthcare Providers
      3. Research & Academic Institutions
  2. U.K.
    1. Drug Type
      1. Praziquantel
      2. Combination Therapies
      3. Emerging Antiparasitic Drugs
    2. Treatment Type
      1. Mass Drug Administration
      2. Targeted Treatment Programs
    3. End-Use
      1. Government & Public Health Organizations
      2. Private Healthcare Providers
      3. Research & Academic Institutions
  3. Germany
  4. France
  5. Spain
  6. Italy
  7. Russia
  8. Nordic
  9. Benelux
  10. Rest of Europe
4. APAC
  1. Market Size and Forecast
    1. Drug Type
      1. Praziquantel
      2. Combination Therapies
      3. Emerging Antiparasitic Drugs
    2. Treatment Type
      1. Mass Drug Administration
      2. Targeted Treatment Programs
    3. End-Use
      1. Government & Public Health Organizations
      2. Private Healthcare Providers
      3. Research & Academic Institutions
  2. China
    1. Drug Type
      1. Praziquantel
      2. Combination Therapies
      3. Emerging Antiparasitic Drugs
    2. Treatment Type
      1. Mass Drug Administration
      2. Targeted Treatment Programs
    3. End-Use
      1. Government & Public Health Organizations
      2. Private Healthcare Providers
      3. Research & Academic Institutions
  3. South Korea
  4. Japan
  5. India
  6. Australia
  7. Singapore
  8. Taiwan
  9. South East Asia
  10. Rest of Asia-Pacific
5. Middle East and Africa
  1. Market Size and Forecast
    1. Drug Type
      1. Praziquantel
      2. Combination Therapies
      3. Emerging Antiparasitic Drugs
    2. Treatment Type
      1. Mass Drug Administration
      2. Targeted Treatment Programs
    3. End-Use
      1. Government & Public Health Organizations
      2. Private Healthcare Providers
      3. Research & Academic Institutions
  2. UAE
    1. Drug Type
      1. Praziquantel
      2. Combination Therapies
      3. Emerging Antiparasitic Drugs
    2. Treatment Type
      1. Mass Drug Administration
      2. Targeted Treatment Programs
    3. End-Use
      1. Government & Public Health Organizations
      2. Private Healthcare Providers
      3. Research & Academic Institutions
  3. Turky
  4. Saudi Arabia
  5. South Africa
  6. Egypt
  7. Nigeria
  8. Rest of MEA
6. LATAM
  1. Market Size and Forecast
    1. Drug Type
      1. Praziquantel
      2. Combination Therapies
      3. Emerging Antiparasitic Drugs
    2. Treatment Type
      1. Mass Drug Administration
      2. Targeted Treatment Programs
    3. End-Use
      1. Government & Public Health Organizations
      2. Private Healthcare Providers
      3. Research & Academic Institutions
  2. Brazil
    1. Drug Type
      1. Praziquantel
      2. Combination Therapies
      3. Emerging Antiparasitic Drugs
    2. Treatment Type
      1. Mass Drug Administration
      2. Targeted Treatment Programs
    3. End-Use
      1. Government & Public Health Organizations
      2. Private Healthcare Providers
      3. Research & Academic Institutions
  3. Mexico
  4. Argentina
  5. Chile
  6. Colombia
  7. Rest of LATAM
Competitive Landscape, 2025
1. Introduction
2. Schistosomiasis Treatment Market Share Analysis, 2025 (%)
  1. Market Share Analysis, 2025
  2. Competition Ranking, 2025
  3. Key Developments & Growth Strategies
    1. Merger & Acquisition
    2. Product Launch
    3. Expansion
  4. Consolidated SWOT Analysis of Key Players
Company Profile
1. Merck & Co., Inc.
  1. Business Overview
  2. Financial Data
  3. Key Product Categories
  4. Recent Developments
2. Bayer AG
3. Novartis AG
4. Pfizer Inc.
5. GlaxoSmithKline plc
6. Sanofi S.A.
7. Johnson & Johnson
8. AstraZeneca plc
9. Cipla Ltd.
10. Sun Pharmaceutical Industries Ltd.

Report Benefits

Table of Contents